Pulmatrix, Inc. (PULM) stock
PULMNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.42+0.08 (+5.97%)
Close on Nov 19, 2026Market cap $5.19MP/E –Yield –
Pulmatrix shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Pulmatrix's shares outstanding was 4M at Sep 30, 2026. For fiscal 2025 it was 4M, up 0.0% from the year before. Over ten years it grew 56.9% a year on average. The highest annual figure on record is 3.45B in fiscal 2022.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4M | 0.0% |
| FY2024 | Dec 31, 2024 | 4M | +0.0% |
| FY2023 | Dec 31, 2023 | 4M | -99.9% |
| FY2022 | Dec 31, 2022 | 3.45B | +127189.2% |
| FY2021 | Dec 31, 2021 | 3M | +88.4% |
| FY2020 | Dec 31, 2020 | 1M | +71.8% |
| FY2019 | Dec 31, 2019 | 1M | +305.5% |
| FY2018 | Dec 31, 2018 | 0M | +113.0% |
| FY2017 | Dec 31, 2017 | 0M | +30.8% |
| FY2016 | Dec 31, 2016 | 0M | +83.1% |
| FY2015 | Dec 31, 2015 | 0M | +4226.2% |
| FY2014 | Dec 31, 2014 | 0M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 4M | 0.0% |
| Q2 FY2026 | Jun 30, 2026 | 4M | 0.0% |
| Q1 FY2026 | Mar 31, 2026 | 4M | 0.0% |
| Q4 FY2025 | Dec 31, 2025 | 4M | 0.0% |
| Q3 FY2025 | Sep 30, 2025 | 4M | 0.0% |
| Q2 FY2025 | Jun 30, 2025 | 4M | 0.0% |
| Q1 FY2025 | Mar 31, 2025 | 4M | 0.0% |
| Q4 FY2024 | Dec 31, 2024 | 4M | -0.0% |
| Q3 FY2024 | Sep 30, 2024 | 4M | 0.0% |
| Q2 FY2024 | Jun 30, 2024 | 4M | 0.0% |
| Q1 FY2024 | Mar 31, 2024 | 4M | +0.0% |
| Q4 FY2023 | Dec 31, 2023 | 4M | -99.9% |
| Q3 FY2023 | Sep 30, 2023 | 4M | -99.9% |
| Q2 FY2023 | Jun 30, 2023 | 4M | -99.9% |
| Q1 FY2023 | Mar 31, 2023 | 4M | +10.7% |
| Q4 FY2022 | Dec 31, 2022 | 3.64B | +126688.6% |
| Q3 FY2022 | Sep 30, 2022 | 3.48B | +123569.9% |
| Q2 FY2022 | Jun 30, 2022 | 3.37B | +119798.5% |
| Q1 FY2022 | Mar 31, 2022 | 3M | +43.3% |
| Q4 FY2021 | Dec 31, 2021 | 3M | +58.9% |
| Q3 FY2021 | Sep 30, 2021 | 3M | +65.8% |
| Q2 FY2021 | Jun 30, 2021 | 3M | +130.8% |
| Q1 FY2021 | Mar 31, 2021 | 2M | +124.9% |
| Q4 FY2020 | Dec 31, 2020 | 2M | +77.8% |
| Q3 FY2020 | Sep 30, 2020 | 2M | +67.2% |
| Q2 FY2020 | Jun 30, 2020 | 1M | +26.9% |
| Q1 FY2020 | Mar 31, 2020 | 1M | +194.8% |
| Q4 FY2019 | Dec 31, 2019 | 1M | +829.5% |
| Q3 FY2019 | Sep 30, 2019 | 1M | +332.5% |
| Q2 FY2019 | Jun 30, 2019 | 1M | +316.8% |
| Q1 FY2019 | Mar 31, 2019 | 0M | +217.4% |
| Q4 FY2018 | Dec 31, 2018 | 0M | +2.8% |
| Q3 FY2018 | Sep 30, 2018 | 0M | +132.3% |
| Q2 FY2018 | Jun 30, 2018 | 0M | +135.8% |
| Q1 FY2018 | Mar 31, 2018 | 0M | +30.3% |
| Q4 FY2017 | Dec 31, 2017 | 0M | +43.2% |
| Q3 FY2017 | Sep 30, 2017 | 0M | – |
| Q2 FY2017 | Jun 30, 2017 | 0M | – |
| Q1 FY2017 | Mar 31, 2017 | 0M | – |
| Q4 FY2016 | Dec 31, 2016 | 0M | – |
See a number that looks wrong?